Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Tubular obstruction induced polycystin upregulation is pro-fibrotic and induced a severe cystic phenotype in adult mice with autosomal dominant polycystic kidney disease: the coexistence of polycystin loss and gain function in ADPKD

View ORCID ProfileMing Wu, View ORCID ProfileYanzhe Wang, Ying Jing, Dongping Chen, Yufeng Xing, Yanfang Bai, Di Huang, Yijing Zhou, Jinghua Hu, Shougang Zhuang, Chaoyang Ye
doi: https://doi.org/10.1101/2021.11.03.467035
Ming Wu
1Department of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
2TCM Institute of Kidney Disease of Shanghai University of Traditional Chinese Medicine
3Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai Key Laboratory of Traditional Chinese Clinical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Ming Wu
  • For correspondence: mingwunl@126.com
Yanzhe Wang
1Department of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
2TCM Institute of Kidney Disease of Shanghai University of Traditional Chinese Medicine
3Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai Key Laboratory of Traditional Chinese Clinical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Yanzhe Wang
Ying Jing
4Department of Nephrology, The 960th Hospital of the PLA Joint Logistics Support Force
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dongping Chen
1Department of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
2TCM Institute of Kidney Disease of Shanghai University of Traditional Chinese Medicine
3Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai Key Laboratory of Traditional Chinese Clinical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yufeng Xing
1Department of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
2TCM Institute of Kidney Disease of Shanghai University of Traditional Chinese Medicine
3Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai Key Laboratory of Traditional Chinese Clinical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yanfang Bai
1Department of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
2TCM Institute of Kidney Disease of Shanghai University of Traditional Chinese Medicine
3Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai Key Laboratory of Traditional Chinese Clinical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Di Huang
1Department of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
2TCM Institute of Kidney Disease of Shanghai University of Traditional Chinese Medicine
3Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai Key Laboratory of Traditional Chinese Clinical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yijing Zhou
5Department of Nephrology, Jiaxing Hospital of Traditional Chinese Medicine, Zhejiang Province
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jinghua Hu
6Department of Biochemistry and Molecular Biology, Mayo Clinic, Rochester, MN, USA; Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN, USA; Mayo Clinic Robert M. and Billie Kelley Pirnie Translational Polycystic Kidney Disease Center, Mayo Clinic, Rochester, MN, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shougang Zhuang
7Department of Medicine, Rhode Island Hospital and Alpert Medical School, Brown University, Providence, RI, R02903, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chaoyang Ye
1Department of Nephrology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
2TCM Institute of Kidney Disease of Shanghai University of Traditional Chinese Medicine
3Key Laboratory of Liver and Kidney Diseases, Ministry of Education, Shanghai Key Laboratory of Traditional Chinese Clinical Medicine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: yechaoyang63@126.com
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract

Mutations in PKD1 (encoding polycystin-1) or PKD2 (encoding polycystin-2) gene cause autosomal dominant polycystic kidney disease (ADPKD), however high levels of polycystins are detected in renal tissues of ADPKD patients. Animal studies showed that loss and gain of function of polycystins are both pathogenic and can induce cystic phenotype in the kidney, which are associated with enhanced renal fibrosis. Recent studies showed that increased expression of polycystins contributes to organ fibrosis. However, the role of polycystins in renal tubulointerstitial fibrosis remains unclear. In this study, we demonstrated that polycystin-1 or polycystin-2 was highly expressed in the kidney of two different fibrotic mouse models and positively correlated with expression of collagen-I. Pharmaceutical inhibition of polycystin-2 with triptolide or genetic knockout of polycystin-2 reduced the expression of epithelial-mesenchymal transition (EMT) markers and deposition of extracellular matrix proteins in fibrotic kidneys. Similarly, conditional knockout of Pkd1 gene also attenuated renal fibrosis in mouse models. Thus, we further hypothesized that inhibition of polycystins delays cyst growth by mitigating renal fibrosis. Here, we showed that polycystin-1 or polycystin-2 was up-regulated in Pkd2 or Pkd1 mice respectively and tightly correlated with the growth of renal cysts and fibrosis development. Genetic deletion of both polycystin-1 and polycystin-2 retarded cyst growth in Pkd1 or Pkd2 mice. Finally, we deleted pkd1 gene in a fibrosis triggered adult ADPKD mouse model at different time point before or after the fibrotic injury. We showed that early and long-term inactivation of Pkd1 delayed fibrosis triggered renal cyst growth in adult Pkd1 mice as compared with mice with late and short-term inactivation of Pkd1 gene. We conclude that tubular obstruction induced polycystin up-regulation is pro-fibrotic and accelerates cyst growth through enhancing renal interstitial fibrosis in ADPKD mice. Our study indicates that ADPKD is caused by both loss and gain function of polycystins. Reduction of the aberrant upregulation of polycystins in cystic kidneys is a therapeutic option for ADPKD patients.

  • Polycystin1 and polycystin-2 are up-regulated in fibrotic kidneys

  • Inhibition or deletion of polycystins inhibits EMT and attenuates renal tubulointerstitial fibrosis

  • Upregulation of polycystin1 or polycystin-2 is positively correlated with fibrosis progression and renal cyst growth in ADPKD mice

  • Double knockout of Pkd1 and Pkd2 gene inhibits renal cyst growth in ADPKD mice

  • Long-term deletion of Pkd1 gene delayed fibrosis triggered renal cyst growth in ADPKD mice

Competing Interest Statement

The authors have declared no competing interest.

Footnotes

  • The title updated;author information updated;Abstract updated; Figure updated;

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 26, 2023.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Tubular obstruction induced polycystin upregulation is pro-fibrotic and induced a severe cystic phenotype in adult mice with autosomal dominant polycystic kidney disease: the coexistence of polycystin loss and gain function in ADPKD
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Tubular obstruction induced polycystin upregulation is pro-fibrotic and induced a severe cystic phenotype in adult mice with autosomal dominant polycystic kidney disease: the coexistence of polycystin loss and gain function in ADPKD
Ming Wu, Yanzhe Wang, Ying Jing, Dongping Chen, Yufeng Xing, Yanfang Bai, Di Huang, Yijing Zhou, Jinghua Hu, Shougang Zhuang, Chaoyang Ye
bioRxiv 2021.11.03.467035; doi: https://doi.org/10.1101/2021.11.03.467035
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Tubular obstruction induced polycystin upregulation is pro-fibrotic and induced a severe cystic phenotype in adult mice with autosomal dominant polycystic kidney disease: the coexistence of polycystin loss and gain function in ADPKD
Ming Wu, Yanzhe Wang, Ying Jing, Dongping Chen, Yufeng Xing, Yanfang Bai, Di Huang, Yijing Zhou, Jinghua Hu, Shougang Zhuang, Chaoyang Ye
bioRxiv 2021.11.03.467035; doi: https://doi.org/10.1101/2021.11.03.467035

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pathology
  • Molecular Biology
Subject Areas
All Articles
  • Animal Behavior and Cognition (4384)
  • Biochemistry (9609)
  • Bioengineering (7103)
  • Bioinformatics (24896)
  • Biophysics (12631)
  • Cancer Biology (9974)
  • Cell Biology (14372)
  • Clinical Trials (138)
  • Developmental Biology (7966)
  • Ecology (12124)
  • Epidemiology (2067)
  • Evolutionary Biology (16001)
  • Genetics (10936)
  • Genomics (14755)
  • Immunology (9880)
  • Microbiology (23697)
  • Molecular Biology (9490)
  • Neuroscience (50924)
  • Paleontology (370)
  • Pathology (1541)
  • Pharmacology and Toxicology (2686)
  • Physiology (4023)
  • Plant Biology (8673)
  • Scientific Communication and Education (1511)
  • Synthetic Biology (2402)
  • Systems Biology (6444)
  • Zoology (1346)